24 May 2018 | 2:03 PM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
526.71
11.25
(2.19 %)
24 May 2018 | 01:49 PM
Change company
  • Open (Rs)
    516.96
  • Prev. close (Rs.)
    515.46
  • High (Rs.)
    528.00
  • Low (Rs.)
    511.55
  • 52W H (Rs.)
    720.90
  • 52W L (Rs.)
    494.50
  • Volume
    20837
  • MCap (Rs in Cr.)
    14,861.79

Stock Market News

Glenmark Pharmaceuticals Ltd. Stock News

Company Name
From Date
To Date
  Glenmark Pharmaceuticals Ltd. | 22 May 2018 | 09:28:00
Glenmark Pharmaceuticals a global pharmaceutical company has said that the company has submitted a New Drug Application (NDA) to the U.S...
  Glenmark Pharmaceuticals Ltd. | 21 May 2018 | 09:29:00
Glenmark Pharmaceuticals has said that it has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Colesevelam Hydrochloride Tablets 625 mg the generic version of Welchol®1 Tablets 625 mg of Daiichi Sankyo Inc...
  Glenmark Pharmaceuticals Ltd. | 18 May 2018 | 09:30:00
Glenmark Pharmaceuticals a global pharmaceutical company has said that it has announced data from a Phase 2a proof-of-concept study of GBR 830 an investigational anti-OX40 monoclonal antibody being studied for the treatment of moderate-to-severe atopic der...
  Glenmark Pharmaceuticals Ltd. | 16 May 2018 | 09:35:00
Glenmark Pharmaceuticals has said that it has launched a generic version of Seretide® Accuhaler® in Denmark. This is Glenmark’s first inhaled respiratory product launch in Europe...
  Glenmark Pharmaceuticals Ltd. | 11 May 2018 | 10:02:00
Glenmark Pharmaceuticals has said that it has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Cream USP 0.05 per cent the generic version of Temovate®1 Cream 0...
  Glenmark Pharmaceuticals Ltd. | 10 May 2018 | 10:03:00
Glenmark Pharmaceuticals a global pharmaceutical company has said that new and updated data on GBR 830 will be presented at the upcoming International Investigative Dermatology Meeting (IID) in Orlando Florida...